Vital Therapies (VTL) Reports In-Line Q3 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Vital Therapies Announces Third Quarter Financial Results
November 3, 2016 4:01 PM EDTSAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Vital Therapies, Inc. (Nasdaq: VTL), a biotherapeutic company developing ELAD®, a cell-based therapy targeting the treatment of acute forms of liver failure, today announced results for the third quarter ended September 30, 2016.
Key Recent Developments
Twenty subjects have been enrolled at sites in the United States and Europe in VTL-308, the Companys phase 3 randomized, controlled, open-label trial, designed to evaluate the ELAD System in... MoreInvesco Closed-End Funds Declare Dividends
November 1, 2016 1:16 PM EDTATLANTA, Nov. 1, 2016 /PRNewswire/ -- The Board of Trustees of each of the Invesco closed-end funds listed below today declared the following dividends.
                                                                Â
EX-DATEÂ Â Â Â Â RECORD DATE
11/10/16Â Â Â Â Â Â Â 11/14/16Â Â Â
REINVEST DATE11/30/16
PAYABLE DATE11/30/16
Name of... More
